These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

245 related items for PubMed ID: 7698223

  • 21. Bcl-2 is an apoptotic target suppressed by both c-Myc and E2F-1.
    Eischen CM, Packham G, Nip J, Fee BE, Hiebert SW, Zambetti GP, Cleveland JL.
    Oncogene; 2001 Oct 25; 20(48):6983-93. PubMed ID: 11704823
    [Abstract] [Full Text] [Related]

  • 22. Bcl-2/Bax: a rheostat that regulates an anti-oxidant pathway and cell death.
    Korsmeyer SJ, Shutter JR, Veis DJ, Merry DE, Oltvai ZN.
    Semin Cancer Biol; 1993 Dec 25; 4(6):327-32. PubMed ID: 8142617
    [Abstract] [Full Text] [Related]

  • 23. Lymphoma development in Bax transgenic mice is inhibited by Bcl-2 and associated with chromosomal instability.
    Luke JJ, Van De Wetering CI, Knudson CM.
    Cell Death Differ; 2003 Jun 25; 10(6):740-8. PubMed ID: 12761582
    [Abstract] [Full Text] [Related]

  • 24. Point mutations in the c-Myc transactivation domain are common in Burkitt's lymphoma and mouse plasmacytomas.
    Bhatia K, Huppi K, Spangler G, Siwarski D, Iyer R, Magrath I.
    Nat Genet; 1993 Sep 25; 5(1):56-61. PubMed ID: 8220424
    [Abstract] [Full Text] [Related]

  • 25. Id2 is dispensable for myc-induced lymphomagenesis.
    Nilsson JA, Nilsson LM, Keller U, Yokota Y, Boyd K, Cleveland JL.
    Cancer Res; 2004 Oct 15; 64(20):7296-301. PubMed ID: 15492249
    [Abstract] [Full Text] [Related]

  • 26. Proviral activation of the tumor suppressor E2a contributes to T cell lymphomagenesis in EmuMyc transgenic mice.
    Mikkers H, Allen J, Berns A.
    Oncogene; 2002 Sep 26; 21(43):6559-66. PubMed ID: 12242653
    [Abstract] [Full Text] [Related]

  • 27. Paradoxical inhibition of c-myc-induced carcinogenesis by Bcl-2 in transgenic mice.
    de La Coste A, Mignon A, Fabre M, Gilbert E, Porteu A, Van Dyke T, Kahn A, Perret C.
    Cancer Res; 1999 Oct 01; 59(19):5017-22. PubMed ID: 10519417
    [Abstract] [Full Text] [Related]

  • 28. Bcl-2 gene promotes haemopoietic cell survival and cooperates with c-myc to immortalize pre-B cells.
    Vaux DL, Cory S, Adams JM.
    Nature; 1988 Sep 29; 335(6189):440-2. PubMed ID: 3262202
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Lymphomagenesis in Emu-myc transgenic mice does not require transgene rearrangement or mutation of myc exon 1.
    Webb E, Barri G, Cory S, Adams JM.
    Mol Biol Med; 1989 Dec 29; 6(6):475-80. PubMed ID: 2699507
    [Abstract] [Full Text] [Related]

  • 31. Cooperative interaction between c-myc and bcl-2 proto-oncogenes.
    Fanidi A, Harrington EA, Evan GI.
    Nature; 1992 Oct 08; 359(6395):554-6. PubMed ID: 1406976
    [Abstract] [Full Text] [Related]

  • 32. Expression of apoptosis-related genes in human head and neck squamous cell carcinomas undergoing p53-mediated programmed cell death.
    Frederick MJ, Holton PR, Hudson M, Wang M, Clayman GL.
    Clin Cancer Res; 1999 Feb 08; 5(2):361-9. PubMed ID: 10037186
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Overexpression of Bcl-2 inhibits alveolar cell apoptosis during involution and accelerates c-myc-induced tumorigenesis of the mammary gland in transgenic mice.
    Jäger R, Herzer U, Schenkel J, Weiher H.
    Oncogene; 1997 Oct 09; 15(15):1787-95. PubMed ID: 9362445
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Carcinogen-induced lymphomagenesis in pim-1 transgenic mice: dose dependence and involvement of myc and ras.
    Breuer M, Wientjens E, Verbeek S, Slebos R, Berns A.
    Cancer Res; 1991 Feb 01; 51(3):958-63. PubMed ID: 1988138
    [Abstract] [Full Text] [Related]

  • 38. Role of bcl-X(L) in the control of apoptosis in murine myeloma cells.
    Gauthier ER, Piché L, Lemieux G, Lemieux R.
    Cancer Res; 1996 Mar 15; 56(6):1451-6. PubMed ID: 8640839
    [Abstract] [Full Text] [Related]

  • 39. Differences between Burkitt's lymphomas and mouse plasmacytomas in the immunoglobulin heavy chain/c-myc recombinations that occur in their chromosomal translocations.
    Müller JR, Janz S, Potter M.
    Cancer Res; 1995 Nov 01; 55(21):5012-8. PubMed ID: 7585544
    [Abstract] [Full Text] [Related]

  • 40. Possible collaboration between c-fos and c-myc proto-oncogene products in in vivo lymphomagenesis.
    Takao S, Sakai N, Aizawa S, Tokuhisa T.
    Kobe J Med Sci; 1991 Oct 01; 37(4-5):227-43. PubMed ID: 1724994
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.